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ABSTRACT 
The aim of this study was to assess the effectiveness of pregraft immunomodulatory artifi-
cial blood exchange (IABX) in a guinea pig-to-rat xeno discordant heart transplantation, using 
an artificial blood (FC43 emulsion: The Green Cross, Japan) in exchange for a large volume 
of whole blood to remove humoral immune factors en bloc from the recipient rat. In the rats 
treated with IABX, rhythmic beating of the grafted heart was maintained for 2 hr, whereas 
the untreated heart beat lasted for only 15.2 ± 5.2 min (n=6). In the graft hearts treated with 
IABX, no pathologic changes such as multiple coronary thromboses due to hyperacute rejec-
tion (HAR) were observed. Humoral immune factors (natural-IgM titer, ACH50 and CH50 
complement activities, platelet count, prothrombin time (PT), activated partial thromboplastin 
time (APTT) and fibrinogen serum concentration), which are thought to contribute to HAR, 
decreased significantly following the IABX treatment. 
We conclude that IABX is an efficient method for prolonging the survival time of guinea pig 
heart xenografts by inhibiting thrombus formation in the xeno-graft heart. It was confirmed 
that IABX could remove recipient humoral immune factors en bloc. 
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The existence of natural antibodies, serum com-
plement activities, coagulation factors and other 
humoral immune factors are part of a well-estab-
lished phenomenon in discordant xenograft trans-
plantations, and commonly lead to hyperacute 
rejection (HAR)1•21•23,24). The aim of this study 
was to assess the effectiveness of a pregraft im-
munomodulatory artificial blood exchange (IABX) 
on a guinea pig-to-rat cardiac transplantation. 
This was accomplished by using a perfluorochem-
ical-based red blood cell substitute (FC43 emul-
sion: The Green Cross, Japan) in exchange for a 
large volume of whole blood to remove humoral 
immune factors en bloc from the rat. 
maintained on a diet of RC4 pellets ( Orientaly 
East, Japan) and the Wistar rats were main-
tained on MF pellets (Orientaly East, Japan). 
Free access to water and food were allowed at all 
times. The temperature and lighting were regu-
lated to maintain a temperature of 20-25 °C and 
a 12-14hr light cycle I day (lights on 07.00hr-). 
All the animals received humane care in com-
pliance with the "Principles of Laboratory Ani-
mals Care" formulated by the National Society 
for Medical Research and the "Guide for the Care 
and Use of Laboratory Animals" prepared by the 
National Academy of Sciences and published by 
the National Institutes of Health (NIH publica-
tion no. 8623, revised 1985). 
MATERIALS AND METHODS 
Animals 
Mature male guinea pigs (mean± S.D. of mean 
body weight: 312±21.5g) of 8-10 weeks of age 
and mature male Wistar rats (mean±S.D. of 
mean body weight: 356 ± 28.4g) of 9-12 weeks of 
age (Hiroshima Experiment, Japan) served as 
cardiac xenograft donors and recipients, respec-
tively. The animals were kept in cages in a labo-
ratory animal house. The guinea pigs were 
Experimental procedures 
Donor animals. 
The guinea pigs (GP) were initially anesthe-
tized with ether, weighed and then given a single 
1.0ml/kg intraperitoneal injection of sodium pen-
tobalbital (Nembutal: Abbott Lab., U.S.A.). The 
GPs were placed in a supine position, and a me-
dian sternotomy was performed. The right and 
left superior vena cava were then ligated with 
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4-0 silk. Next, cold (4°C) crystalloid potassium 
cardioplegia (GIK solution: K+: 25mEq/L; HC03: 
4.4mEq/L; pH 7.78; 350 mOsm) was perfused ret-
rogradely via a catheter inserted through the root 
of the inferior vena cava at a dose of 0.1 ml/kg. 
The left atrium was ligated with 4-0 silk, and 
the pulmonary artery and aorta were transected 
3-4 mm above their origins in the heart. After 
perfusion of the ventricles and atria with a saline 
solution containing 200 U/ml of heparin, the do-
nor heart was placed in a saline bath at 4 °C for 
about 30-45 min. 
Recipient animals. 
The Wistar rats (WR) were anesthetized and 
placed in a supine position. A midline neck inci-
sion was made, and the trachea was exposed. 
Then a 14 gauge catheter (internal diam. 
1.75mm; outer diam. 2.lmm; Terumo, Japan) was 
inserted into the trachea. After this procedure, 
the respiration of the rat was controlled by a ven-
tilator (EVM-50A: AIKA, Japan) at a tidal vol-
ume of 2.5 ml and a rate of 80/min with 100% 02. 
The right femoral artery and vein were then ex-
posed in the right inguinal region. Two 24 gauge 
polypropylene catheters (int. diam. 0.47mm; outer 
diam. 0.67mm; Terumo, Japan) were inserted into 
the femoral artery and vein. 
Immunomodulatory Artificial Blood 
Exchange (IABX). 
Isovolumetric blood exchange was performed 
with a novel, specially constructed apparatus6). A 
diagram of this circuit is shown in Fig. 1. The 
blood substitute (FC43 emulsion; Table 1) and sa-
line were warmed to 38 °C and oxygenated with 
5% C02-95% 02 mixture gas in a bubble oxyge-
nator. Then the FC43 emulsion was infused via 
the venous catheter at a rate of 1 ml/min contin-
uously by a JMS infuser M-04 pump (JMS, Ja-
Heat 
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( 38.5°C) 
Bubble Oxygenation 
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Femoral Femoral 
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Fig. 1. Diagram of the blood exchange apparatus 
pan), whilst the blood was simultaneously 
removed at the same rate from the arterial cathe-
ter by the same pump. The arterial effluent was 
collected serially into plastic tubes kept in a cool-
er box at 0°C, and the hematocrit was measured 
every 5 min in these serial samples. When the 
hematocrit fell below 20% in experimental group 
III and 10% in experimental group IV, the ex-
change procedure was discontinued. The final he-
matocrit was confirmed by the last blood sample. 
The blood pressure and heart rate were also mon-
itored at 5 min intervals with a type 45363 pres-
sure transducer connected to the arterial 
catheter, and the readings were displayed on a 
Multisuper type 2F21 recorder (SAN-EI Instru-
ment, Japan). If the blood pressure fell below 
70mmHg, the exchange procedure was also dis-
continued. The circuit was composed of polyethyl-
ene tubes (int. diam. 1.75mm; outer diam. 
2. lmm; Terumo, Japan). An air filter (Pole filter: 
max. pore size 0.2µm; Mera, Japan) was placed in 
the affluent line to the oxygenator to prevent bac-
terial infection. The total volume of the circuit 
was about 2 ml. The blood exchange continued 
until the target hematocrit (%) was reached. At 
the end of the exchange, the WR were given a 
supplementary infusion of 1.5 ml FC43 emulsion 
lOOg-1 body weight to aid survival31). The overall 
exchange usually lasted 20-30 min, depending on 
the final target hematocrit. 
Heart transplantation. 
Heterotopic heart transplantation was per-
formed using a modified Cuff technique, accord-
ing to the method of Heron 7). After isovolumetric 
blood exchange, the recipient WR was maintained 
under anesthesia and placed in a supine position. 
The right jugular vein and common carotid artery 
were then exposed and dissected free. The pulmo-
nary artery of the graft heart was connected to 
the right jugular vein of the recipient WR with a 
12 gauge catheter (2mm long; outer diam. 
1.65mm; Portex, U.K.). The innominate artery of 
the graft heart was connected to the right com-
mon carotid artery of the recipient WR with a 16 
gauge catheter (2mm long; outer diam. 1.02mm; 
Portex, U.K.). Within a few minutes following re-
perfusion, the xeno-grafted heart resumed its si-
nus rhythm. The operative duration ranged from 
20 to 30 min, with a success rate of approximate-
ly 90%. The total ischemic time varied between 
45 to 60 min. 
Analytical procedures 
Graft heart beating time. 
The graft heart beating time (GH-BT) was mea-
sured by direct observation when the neck surgi-
cal fields were opened. 
Blood samples. 
Arterial effluent samples were collected into 
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Table 1. Composition of FC43 emulsion, structural formulae ofFC43 (perfluorotributylamine) and Pluronic F-68 
(polyxypropylene-polyxyethylene-copolymer) 
Composition of FC43 emulsion 
FC43 (perfluorotributylamine) 
Pluronic F-68 
(polyxypropylene-polyxyethylene-copolymer) 
NaCl 
KCl 
MgCl26H20 
CaCl22H20 
NaHC03 
Glucose 
Hydroxyethyl starch 
20 w/v% 
2.56w/v% 
0.60 w/v% 
0.034w/v% 
0.043w/v% 
0.036w/v% 
0.210w/v% 
0.180w/v% 
3.0 w/v% 
in pyrogen-free distilled water, autoclave-sterilized. 
Structural formula of FC43(perfluorotributylamine) 
CF3-CF2-CF2-CF2-N-CF2-CF2-CF2-CF3 
CF3-CF2-CF2-CF21 
Structural formula of Pluronic F-68 
(polyxypropylene-polyxyethylene-copolymer) 
HO(CH2CH20)a( vHCH20 )be CH2CH20 )cH 
CH3 
Physiolochemical properties ofFC43 emulsion: Osmotic pressure, 309 mOsm; Oncotic pressure, 395 mmH20; Weight-
average particle size, ca.0.1,um, freed from 0.6,um or greater particles. Pluronic F-68 is a non-ionic surfactant, added 
to emulsify FC43. 
plastic tubes before and after the blood exchange 
procedure, but prior to heart transplantation. For 
immunologic analysis, the samples were centri-
fuged at 2500 r.p.m. for 10 min at -4°C to obtain 
the serum. The serum was then stored at -70°C 
and, in principle, the frozen serum was defrosted 
only once prior to the assay. For coagulation anal-
ysis, the samples were collected into plastic tubes 
containing sodium citrate, and the serum was ob-
tained by the same procedure described above. 
Hematocrit & platelet counts. 
The hematocrit was measured automatically by 
a HITACHI MC-200 microhematocrit centrifuge 
(Hitachi, Japan). The platelet count and the mea-
surement of other blood cells were performed au-
tomatically by a Celltac a Counter (Nihon 
Kohden, Japan). The samples were diluted ac-
cordingly using Isotonic III solution. 
Complement hemolysis assay (CH50, ACH50). 
The CH50 (classical pathway assay) was mea-
sured by the microtiter method according to May-
er18). ACH50 (alternative pathway assay) was 
measured according to the method of Platts-
Milles and Ishizuka25) with a slight modification 
in that sheep erythrocytes were substituted as 
target cells. 
lgM titer. 
The IgM titer was measured by the general ra-
dial immunodiffusion (RID) method17) using a 
Binding Site RID kit (The Binding Site Limited, 
England). 
Examination of blood coagulation factors. 
The prothrombin time (PT), activated partial 
thromboplastin time (APTT), and fibrinogen se-
rum concentration (FBG) were measured auto-
matically by a CA-5000 automated blood 
coagulation analyzer (Toa Medical Electronics, 
Japan) as indices for coagulation activity. This 
method quantifies clots by detecting scattered 
light intensity (percentage test end-point detec-
tion method)22). 
Histological examination. 
The xeno-grafted hearts were removed shortly 
before they stopped. For electron microscopic ex-
amination, small pieces of the left ventricular 
wall were excised from grafted hearts treated 
with or without IABX. These tissues were fixed 
with 3% phosphate-buffered glutaraldehyde for 
2hr and post-fixed with 1 % phosphate-buffered 
Os04 for lhr. Then they were dehydrated 
through a graded alcohol series, embedded in 
epoxy resin, and thin sections cut with a Porter-
Blum ultramicrotome equipped with glass knives. 
The sections were stained with uranyl acetate 
and lead citrate, and finally observed with a Hi-
tachi H-7000 electron microscope (Hitachi, Ja-
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pan). Additional tissues were fixed with 10% 
formalin, embedded in paraffin, and stained with 
hematoxylin I eosin for light microscopy. 
Experimental design. 
The animals were divided into four groups. 
Group I (control) consisted of 6 guinea pig-to-rat 
hearts transplanted in untreated recipients. 
Group II (saline exchange control) consisted of 6 
animals in which the effect of blood exchange 
with saline was studied to the limit of hemody-
namic parameters. Group III (partial exchange 
with FC43 emulsion; Ht=ll-20%) and group IV 
(total exchange with FC43 emulsion; Ht~ 10%) 
examined the effects of IABX on guinea pig-to-rat 
heart xenograft beating time in 9 and 10 ani-
mals, respectively. 
Statistical Analysis. 
Differences in the graft heart beating times 
were compared using the Wilcoxon rank-sum test, 
and were considered to be statistically significant 
if p values were less than 0.01. For the blood 
examinations, comparisons were made between 
values before and after the blood exchange with 
paired Student's t test. Differences were consid-
ered to be statistically significant if p values were 
less than 0.01. Comparisons were also made be-
tween the saline exchange group and IABX 
groups in every reduction ratio with unpaired 
Student's t test. Differences were considered to be 
statistically significant if p values were less than 
0.01. 
RESULTS 
Graft heart beating time. 
Nineteen rats were eligible for the IABX study. 
The graft heart beating times (GH-BT) in the 4 
different experimental groups are shown in Table 
2. The untreated rats (group I; Ht=45.5 ± 5.8%) 
showed a hyperacute rejection of the xenograft 
within 15.2 ± 5.8 min. Rats which had their whole 
blood exchanged to the limit of hemodynamics 
with saline (group II; Ht=29.8 ± 3.2%) did not 
have a significantly different graft heart beating 
time (GH-BT=l3. 7 ± 3.8 min, NS vs group I). In 
group III, which was treated by a partial ex-
change with FC43 emulsion (Ht=15.0 ± 3.3%), the 
graft heart beating time was prolonged to 
166.9 ± 27.2 min (p=0.0015 vs group I, p=0.0027 
vs group II). In group IV, which was treated by 
a total exchange with FC43 emulsion 
(Ht=6.2 ± 2.4%), the graft heart beating time was 
prolonged to 151.6 ± 25.1 min (p=0.0011 vs group 
I, p=0.0011 vs group II). There were no signifi-
cant differences in the graft heart beating time 
between groups III and IV. 
Blood examinations. 
In the saline exchange group and the two IABX 
groups, the values of the humoral immune factors 
(platelet count, CH50 , ACH50, IgM titer, PT, 
APTT and FBG; expressed as a mean±SD) after 
the blood exchange but before the transplant 
were compared to the values before the blood ex-
change (Table 3.). Furthermore, the reduction ra-
tio after the blood exchange procedure was 
calculated by the following equation, and ex-
pressed as a percentage (mean± SD): reduction 
ratio after blood exchange = (value after blood 
exchange I value before blood exchange) x 100%. 
In group II (saline exchange to the limit of 
hemodynamics), 5 rats were examined. The val-
ues of the platelet count, CH50, ACH50, IgM tit-
er and FBG after the blood exchange decreased 
significantly (p<0.01) as compared with the val-
ues before the blood exchange. In contrast, there 
were no significant differences (p>0.05) in the 
values for the PT and APTT before and after the 
blood exchange. The ratio after the blood ex-
change for the hematocrit decreased from 100% 
to 64.1±6.3%. The reduction ratio after the blood 
exchange was calculated in the platelet count 
(79.0±4.7%), CH50 (64.6±9.1%), ACH50 
Table 2. Graft heart beating time (GH-BT) in each group 
Groups No. Blood exchange parts procedure 
I 6 
II 6 Saline exchange to the limit of hemodynamics 
Partial exchange with 
III 9 FC43 emulsion 
(Ht=ll-20%) 
Total exchange with 
IV 10 FC43 emulsion 
(Ht~ 10%) 
*Wilcoxon rank-sum test 
Ht(%) 
Mean±SD 
45.5±5.8 
29.8±3.2 
15.0±3.3 
6.2±2.4 
Graft heart beating time 
Individual results 
(min) 
9, 11, 12, 18, 18,22 
9,9, 14, 16, 17, 17 
125, 133, 152, 155, 167, 
181, 189, 194,203 
102, 132, 135, 144, 150, 
156, 157, 178, 180, 182 
Mean±SD 
15.2± 5.2 
13.7± 3.8 
166.9±27.2 
151.6±25.1 
P value* 
NS vs. I 
<0.01 vs. I 
<0.01 vs. II 
<0.01 vs. I 
<0.01 vs. II 
NS vs. III 
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Table 3. Changes in humoral immune factors by blood exchange in group II, III and IV 
Group Procedure HT(%) PLT CH50 ACH50 IgM FBG PT APTT ( x 104/mm3) (U/ml) (U/ml) (mg/liter) (mg/dl) (sec) (sec) 
before blood 46.6 98.0 52.1 292.2 1108.7 191.6 14.0 52.4 [exchange ±1.9 ±5.6 ±3.l ±29.4 ±81.0 ±15.5 ±0.1 ±3.7 J II NS NS 
after blood 28.9 77.5 33.5 174.8 901.7 166.2 13.4 48.8 
exchange ±2.6 ±7.9 ±3.5 ±20.6 ±87.3 ±18.9 ±0.6 ±3.8 
before blood 48.2 109.7 55.9 287.7 1117.7 209.4 14.1 48.6 [exchange ±3.6 ±16.3 ±5.3 ±28.4 ±78.7 ±38.7 ±0.2 ±5.1 
III 
after blood 15.0 37.2 <7.7 50.6 603.3 12.8 25.4 86.0 
exchange (IABX) ±2.7 ±6.4 ±3.2 ±17.3 ± 173.2 ±6.3 ±5.1 ±14.4 
before blood 46.0 103.2 53.9 209.8 1098.3 205.0 14.0 48.4 [exchange ±3.2 ±7.3 ±5.8 ±59.4 ±80.2 ±44.9 ±0.6 ±6.2 
IV 
after blood 7.6 17.8 
<6.2 18.0 321.2 <10 44.6 149.0 
exchange (IABX) ± 1.5 ±5.5 ±6.8 ±70.2 ±16.8 ±28.5 
Ht, hematocrit; PLT, platelet count; IgM, Immunoglobulin M titer; FBG, fibrinogen serum concentration; PT, prothrom-
bin time; APTT, activated partial thromboplastin time. Every value expressed as a mean± SD. All of the values after 
the blood exchange decreased or increased significantly (p<0.01) as compared with values before the blood exchange, 
except the values for PT and APTT in group II. 
(60.1±7.5%), IgM titer (81.5±4.5%) and FBG 
(86.6 ± 3.2%). Each of these values decreased sig-
nificantly (p<0.01) after the blood exchange as 
compared with values before the blood exchange. 
On the other hand, there were no significant in-
creases in the ratio for the PT (95.4 ± 4.3%) and 
APTT (93.9±6.7%) after the blood exchange. 
In group III (partial exchange with FC43 
emulsion; Ht=ll-20%), 5 rats were examined. All 
values of the humoral immune factors (platelet 
count, CH50, ACH50, IgM titer, FBG, PT and 
APTT) decreased or increased significantly 
(p<0.01) after the blood exchange as compared 
with the corresponding values before the blood 
exchange. Moreover, the reduction ratio after the 
blood exchange for the hematocrit decreased from 
100% to 31.1±5.3%. There were marked de-
creases in the reduction ratio after the blood ex-
change for the platelet count (34.3 ± 5.9%), CH50 
( <14.0 ± 6.2%), ACH50 (18.2 ± 8.3%), IgM titer 
(53.3±12.3%) and FBG (<6.1±1.5%). There were 
also marked increases in the reduction ratio after 
the blood exchange for the PT (179.1±33.9%) and 
APTT (178. 7 ± 35.0%). All of the ratios after the 
blood exchange showed significant differences 
(p<0.01) as compared with ratios before the blood 
exchange (= 100%). 
In group IV (total exchange with FC43 emul-
sion; Ht~ 10%), 5 rats were examined. All values 
of the humoral immune factors (platelet count, 
CH50, ACH50, IgM titer, FBG, PT and APTT) 
decreased or increased significantly (p<0.01) after 
the blood exchange as compared with correspond-
ing values before the blood exchange .. Further-
more, the reduction ratio for the hematocrit after 
the blood exchange decreased from 100% to 
17.4 ± 3. 6%. There were marked decreases in the 
reduction ratio after the blood exchange for the 
platelet count (17.0±4.6%), CH50 (<11.6±1.2%), 
ACH50 (6.5 ± 3.0%), IgM titer (29.2 ± 5.6%) and 
FBG (<5.1±1.0%). There were also marked in-
creases after the the blood exchange in the reduc-
tion ratios for the PT (320.1± 121.1%) and APTT 
(317.1±90.8%). All of the ratios after the blood 
exchange showed significant differences (p<0.01) 
from those before the blood exchange. 
Comparisons between the saline exchange 
group and the IABX groups about the re-
duction ratio in all humoral immune fac-
tors. 
In every reduction ratio between the IABX 
groups and the saline exchange group there was 
a significant difference (p<O. 0005, except in IgM 
between group II and III; p<0.001) (Fig. 2). 
Histological examinations. 
Light microscopic examination. 
Light microscopic examination of the xeno-
grafted hearts in groups I (Fig. 3a) and II shortly 
before the heart stopped beating showed that the 
coronary vessels were markedly dilated and filled 
with erythrocytes. Erythrocytic and thrombocytic 
thrombi were frequently observed in the coronary 
vessels, and the myocardial cells in the left ven-
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Fig. 2. Reduction ratio after blood exchange in the 
saline exchange group and IABX groups. Every re-
duction ratio in the IABX groups showed a signifi-
cant difference compared with the ratio in the sa-
line exchange group (*p<0.0005; **p<0.001). For ab-
breviations and explanations, see Table 3. 
Fig. 3. Light microscopic examination of grafted 
hearts in group I (a; x 270) revealed that erythro-
cytic and thrombocytic thrombi were recognized fre-
quently in coronary arteries and veins shortly be-
fore the heart stopped. Degenerative and necrotic 
myocardial cells containing pyknotic nuclei and eo-
sinophilic cytoplasm were scattered in the left ven-
tricular wall. On the other hand, these changes 
were not observed in animals of group IV treated 
with IABX (b; x 270) shortly before the grafted 
heart stopped. 
tricular wall were markedly stretched and edem-
atous. Degenerating, necrotic myocardial cells 
containing pyknotic nuclei and eosinophilic cyto-
plasm were also scattered throughout the left 
ventricular wall. The interstitium was markedly 
edematous, with diffuse extravasation. In con-
trast, in the IABX treated groups, vascular di-
latation and thrombus formation were not 
observed in the grafted heart (Fig. 3b). 
Electron microscopic examination. 
Electron microscopy of the grafted heart in 
groups I and II revealed that many thrombocytes 
had adhered to the endothelial cell surfaces by 10 
minutes after the transplantation (Fig. 4a). At 
this stage, the capillary endothelial cells ap-
peared to be stretched. In addition to the adher-
ing thrombocytes, vacuolar changes were 
frequently recognized in these endothelial cells. 
By the time of rejection, most endothelial cells 
had degenerated markedly and contained pyknot-
ic nuclei (Fig. 4b). The cytoplasm of these degen-
erated cells became discontinuous and many 
thrombocytes were in direct contact with the 
basement membrane of these capillary vessels. 
Extravasations were also frequently observed 
around these damaged capillaries. Endothelial 
cells in the coronary arteries and veins showed 
severe degenerative changes with large hydropic 
vacuoles, swollen cytoplasmic projections and 
bleb formation. The arterial and venous luminae 
were frequently filled with aggregated thromobo-
cytic thrombi (Figs. 4c and 4d). 
In the IABX treated groups, thrombocyte adhe-
sion and erythrocytic or thrombocytic thrombi 
were not found, and the endothelial cells re-
mained well-preserved until 2 hours after trans-
plantation (Figs. 5a and 5b). 
DISCUSSION 
Treatment by human organ allotransplantation 
is severely restricted due to the lack of donor or-
gans. Thus, experimental xenotransplantation 
and the feasibility of using substitute donor 
organs from nonhuman sources have been 
studied l,4). However, no effective immuno-
suppressive methods have been developed for 
xenotransplantation. In xenotransplantation, the 
recipient humoral immunity constitutes the 
initial phase of rejection; this immunity is not 
inhibited by cellular immunosuppressive agents 
used in clinical allotransplantation. Humoral 
immunity is activated even in unsensititized 
xenotransplantation subjects23•24). Species 
combinations in which rejection occurs most se-
verely and within only a few hours are consid-
ered to be xeno-discordant combinations3). This 
type of rejection is termed HAR, and the graft is 
rejected immediately because of multiple thrombi 
in the vessels. Although the humoral immuno-
suppressive methods presently available have 
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Fig. 4. Electron microscopic findings of the grafted heart in group I showed that numerous thrombo-
cytes adhered to the endothelial cell surface at 10 min after transplantation (a; x 5900). At the time 
of rejection, capillaries were filled with erythrocytes and thrombocytes, and endothelial cells were de-
generative and necrotic (b; x 5900). In the arteriole (c; x 4400) and venule (d; x 4200) numerous throm-
bocytes aggregated and formed thrombocytic thrombus. 
some effect on graft survival, there are no ade-
quate methods to counteract the HAR12,14,21,30). 
However, if grafts from discordant species could 
be used, then the utility of treatment by trans-
plantation would be extended. 
IABX is a new immunosuppressive technique 
which removes a large volume of humoral im-
mune factors en bloc by exchanging whole blood 
for artificial blood. In this study we used FC43 
emulsion as a red cell substitute (RCS). FC43 
emulsion was developed as a pefluorochemical 
(PFC)-based RCS and has been studied since the 
1970s. FC43 emulsion is one of the most biochem-
ically stable PFC-based RCS in vivo5•28•32\ and 
its pH, osmotic pressure, and electrolyte composi-
tion are ideally suited for administration in 
vivo19). 
In this study, we used a xeno-discordant heart 
transplantation model to induce HAR. In this 
model, the graft heart beating stopped almost im-
mediately because of multiple thrombi in the cor-
onary arteries and veins. Therefore, we tested the 
effectiveness ofIABX for extending the GH-BT in 
this model. As shown in Table 2, the xenografted 
hearts ceased beating by about 15 min after re-
perfusion in the untreated and saline exchange 
groups, whereas the heart beat was maintained 
in the IABX groups for 150-160 min after reper-
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Fig. 5. Electron microscopic findings of the grafted 
heart treated with IABX · (group IV) showed that 
capillary endothelial cel~s of arterial side (a; 
x 5800) and venous side Cb; x 4400) were well pre-
served and thrombus formation could not be found 
at 2 hr after transplantat~on. 
fusion. These results indicate that IABX was 
effective as a pregraft immunomodulatory 
procedure in prolonging the GH-BT in this xeno-
transplantation model, and that the use of artifi-
cial blood substitutes may be effective for 
removing humoral immune factors in cases of 
large blood volume exchange. It was impossible to 
decrease the hematocrit below about 30% in the 
saline exchange group because of hemodynamic 
limitations, and humoral immune factors were 
not reduced sufficiently. 
Although the mechanisms underlying the HAR 
are not completely understood, humoral immune 
factors have been thought to contribute substan-
tially to the HAR 1•21•23•24). Our data confirm 
these immune factors can be significantly atte-
nuated by IABX, and thus would lessen the ex-
tent of HAR. 
Morphologically, endothelial cell damage and 
numerous thrombi were found in the coronary 
vessels of grafted hearts in groups I and II. 
Therefore, these myocardial cells were probably 
injured by the severe acute ischemia caused by 
the stoppage of the coronary circulation10•15). 
However, in grafted hearts treated with IABX 
(groups III and IV), neither endothelial cell dam-
age nor thrombus formation were found in the 
coronary vessels, and the heart beating was pro-
longed for over 2 hr. These findings indicate that 
IABX treatment inhibited thrombus formation, 
and had a protective effect on the endothelial 
cells of the grafted heart by removing the humo-
ral immune factors which are activated in HAR. 
Whilst under general anesthesia the recipient 
rats did not receive any additional infusions after 
the blood exchange procedure for about 2 hr, ex-
c~pt for the supplementary infusion of 1.5 ml 
FC43 emulsion lOOg-1 body weight to aid surviv-
al. This was done so as not to change the initial 
target hematocrit. The arterial blood pressure of 
the recipient rats fell gradually from about 2 hr 
onwards after the blood exchange. Thus there is 
a ·possibility that the grafted hearts stopped un-
der the influence of low perfusion pressure in the 
re~ipient rats. In addition, it has been reported 
by; some investigators that FC43 emulsion has 
some immunosuppressive effects2•13•20>. Both of 
these factors must be considered in assessing the 
influence of blood substitutes on HAR. 
IABX has an advantage over conventional 
piasmapheresis for immune-absorption9,11,26,3o) 
because IABX can remove lymphocytes, 
pl~telets16•27•29) and other unknown immunoreac-
tive mediators to HAR en bloc. This procedure is 
simpler and easier to perform than plasmaphere-
sis. Moreover, there is no risk of infection from 
using human origin blood substitutes. 
As new immunosuppressive agents are devel-
oped in the future, the administration of an im-
munosuppressant combined with IABX may 
prove to be more effective because this procedure 
can remove humoral immune reactive factors8) 
and administer the agent in large quantities (in 
the case of a rescue therapy) at the same time. 
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